Geovax Labs (GOVX)

$0.18 -0.02 (-9.23%)
Market Cap 6.22M
Revenue (ttm) 3.95M
Net Income (ttm) -24.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -632.66%
Debt to Equity Ratio 0.00
Volume 3,206,649
Avg Vol 2,079,406
Day's Range N/A - N/A
Shares Out 30.06M
Stochastic %K 68%
Beta 3.67
Analysts Strong Sell
Price Target $9.62

Company Profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tu...

Industry: Biotechnology
Sector: Healthcare
Phone: 678 384 7220
Fax: 678 384 7281
Address:
1900 Lake Park Drive, Suite 380, Smyrna, United States
ChartChartist
ChartChartist Jan. 25 at 7:49 PM
$GOVX so popular, when it wants it will $ONFO moon runs it once in awhile, pretty dry now keep an alert on $DXST quietly breaking out
0 · Reply
hvlgroup
hvlgroup Jan. 25 at 6:47 PM
$GOVX Zacks has Govx forecast at $200.00 to 300.00+ per share. How is that possible?
0 · Reply
LongEddiesPicksToday
LongEddiesPicksToday Jan. 24 at 12:22 AM
We give the alerts before all the paid services...really this should be paid for. I pay for the system and it's yours free. Join our club if you want the newest plays at the time they are in play. Do not pay to be late! The world is in your hands...for free. $GOVX and $ONFO bullish $FATBB green $NXTT great news
0 · Reply
stockboy2030
stockboy2030 Jan. 23 at 7:15 PM
$GOVX 🚀🚀💥💥💥💥💥
0 · Reply
topstockalerts
topstockalerts Jan. 23 at 5:20 PM
$GOVX Showing strong relative strength versus the market. It’s holding gains while others chop. That’s a bullish sign.
0 · Reply
jsmith14
jsmith14 Jan. 23 at 3:16 PM
$GOVX good upside potential
0 · Reply
DeezNuttz
DeezNuttz Jan. 23 at 12:59 PM
$GOVX
1 · Reply
truthdotphd
truthdotphd Jan. 22 at 7:20 PM
$GOVX 3x gain opportunity
0 · Reply
Waffels
Waffels Jan. 22 at 7:06 PM
$GOVX this company have alots of integrity. i like alot
0 · Reply
stockboy2030
stockboy2030 Jan. 22 at 4:43 PM
$GOVX 🚀🚀🚀🚀🚀🚀
0 · Reply
Latest News on GOVX
GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 10:41 PM EST - 2 months ago

GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript

GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript

Jul 28, 2025, 7:43 PM EDT - 6 months ago

GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript

GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript

May 1, 2025, 8:58 PM EDT - 9 months ago

GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript

GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 8:53 PM EDT - 10 months ago

GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

Dec 9, 2024, 9:00 AM EST - 1 year ago

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

Nov 26, 2024, 9:00 AM EST - 1 year ago

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:33 PM EST - 1 year ago

GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 12, 2024, 4:00 PM EST - 1 year ago

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

Nov 5, 2024, 9:00 AM EST - 1 year ago

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Oct 2, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

GeoVax to Participate in Upcoming Investor Conferences in September

Sep 3, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Participate in Upcoming Investor Conferences in September

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

Aug 28, 2024, 8:59 PM EDT - 1 year ago

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

GeoVax's stock slides 20% after company raises $8.5 million in stock sale

Aug 20, 2024, 8:09 AM EDT - 1 year ago

GeoVax's stock slides 20% after company raises $8.5 million in stock sale

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

Aug 20, 2024, 7:45 AM EDT - 1 year ago

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

Aug 20, 2024, 7:00 AM EDT - 1 year ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GDTC GOSS IMRN

GeoVax's stock soars 54% to lead rally in companies developing mpox treatments

Aug 19, 2024, 7:30 AM EDT - 1 year ago

GeoVax's stock soars 54% to lead rally in companies developing mpox treatments

GeoVax to Present at the Emerging Growth Conference on August 21, 2024

Aug 15, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present at the Emerging Growth Conference on August 21, 2024

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

Aug 15, 2024, 8:36 AM EDT - 1 year ago

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

EBS SIGA

GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 6:15 AM EDT - 1 year ago

GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call Transcript

GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

Aug 8, 2024, 9:00 AM EDT - 1 year ago

GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 6, 2024, 4:00 PM EDT - 1 year ago

GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update

Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

Jul 31, 2024, 10:15 AM EDT - 1 year ago

Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript

May 14, 2024, 8:01 PM EDT - 1 year ago

GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

Apr 4, 2024, 12:30 PM EDT - 1 year ago

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress

Mar 28, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress

GeoVax to Present at the 36th Annual Roth Conference

Mar 12, 2024, 9:00 AM EDT - 2 years ago

GeoVax to Present at the 36th Annual Roth Conference

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

Mar 6, 2024, 9:00 AM EST - 2 years ago

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript

Mar 1, 2024, 2:34 AM EST - 2 years ago

GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

Feb 29, 2024, 4:00 PM EST - 2 years ago

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

Feb 22, 2024, 9:00 AM EST - 2 years ago

GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

GeoVax to Present at the 2024 BIO CEO & Investor Conference

Feb 19, 2024, 9:00 AM EST - 2 years ago

GeoVax to Present at the 2024 BIO CEO & Investor Conference

GeoVax Announces Multiple Patent Issuances and Allowances

Feb 13, 2024, 9:00 AM EST - 2 years ago

GeoVax Announces Multiple Patent Issuances and Allowances

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster

Feb 6, 2024, 9:00 AM EST - 2 years ago

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

Jan 29, 2024, 9:00 AM EST - 2 years ago

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

Jan 8, 2024, 9:00 AM EST - 2 years ago

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

Jan 4, 2024, 9:00 AM EST - 2 years ago

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

GeoVax Announces Issuance of Malaria Vaccine Patent

Jan 3, 2024, 9:00 AM EST - 2 years ago

GeoVax Announces Issuance of Malaria Vaccine Patent

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

Dec 27, 2023, 9:00 AM EST - 2 years ago

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox

Dec 19, 2023, 9:00 AM EST - 2 years ago

GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

Nov 30, 2023, 4:30 PM EST - 2 years ago

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

GeoVax to Participate in Upcoming December Investor Events

Nov 29, 2023, 9:00 AM EST - 2 years ago

GeoVax to Participate in Upcoming December Investor Events

GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress

Nov 28, 2023, 9:00 AM EST - 2 years ago

GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress

Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023

Nov 14, 2023, 9:00 AM EST - 2 years ago

Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023

GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 9:26 PM EST - 2 years ago

GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript

GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 8, 2023, 4:00 PM EST - 2 years ago

GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update

GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine

Oct 30, 2023, 9:00 AM EDT - 2 years ago

GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine

GeoVax to Participate in Upcoming November Investor and Industry Events

Oct 25, 2023, 9:00 AM EDT - 2 years ago

GeoVax to Participate in Upcoming November Investor and Industry Events

GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities

Oct 24, 2023, 9:00 AM EDT - 2 years ago

GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities

GeoVax Receives Notice of Allowance for Marburg Vaccine Patent

Oct 9, 2023, 9:00 AM EDT - 2 years ago

GeoVax Receives Notice of Allowance for Marburg Vaccine Patent

GeoVax Receives Notice of Allowance for HIV Vaccine Patent

Oct 5, 2023, 9:00 AM EDT - 2 years ago

GeoVax Receives Notice of Allowance for HIV Vaccine Patent

ChartChartist
ChartChartist Jan. 25 at 7:49 PM
$GOVX so popular, when it wants it will $ONFO moon runs it once in awhile, pretty dry now keep an alert on $DXST quietly breaking out
0 · Reply
hvlgroup
hvlgroup Jan. 25 at 6:47 PM
$GOVX Zacks has Govx forecast at $200.00 to 300.00+ per share. How is that possible?
0 · Reply
LongEddiesPicksToday
LongEddiesPicksToday Jan. 24 at 12:22 AM
We give the alerts before all the paid services...really this should be paid for. I pay for the system and it's yours free. Join our club if you want the newest plays at the time they are in play. Do not pay to be late! The world is in your hands...for free. $GOVX and $ONFO bullish $FATBB green $NXTT great news
0 · Reply
stockboy2030
stockboy2030 Jan. 23 at 7:15 PM
$GOVX 🚀🚀💥💥💥💥💥
0 · Reply
topstockalerts
topstockalerts Jan. 23 at 5:20 PM
$GOVX Showing strong relative strength versus the market. It’s holding gains while others chop. That’s a bullish sign.
0 · Reply
jsmith14
jsmith14 Jan. 23 at 3:16 PM
$GOVX good upside potential
0 · Reply
DeezNuttz
DeezNuttz Jan. 23 at 12:59 PM
$GOVX
1 · Reply
truthdotphd
truthdotphd Jan. 22 at 7:20 PM
$GOVX 3x gain opportunity
0 · Reply
Waffels
Waffels Jan. 22 at 7:06 PM
$GOVX this company have alots of integrity. i like alot
0 · Reply
stockboy2030
stockboy2030 Jan. 22 at 4:43 PM
$GOVX 🚀🚀🚀🚀🚀🚀
0 · Reply
abcmart
abcmart Jan. 22 at 10:16 AM
$GOVX pendemic soon?
0 · Reply
Ueberschlaefer
Ueberschlaefer Jan. 22 at 4:35 AM
$GOVX you think retailers haven't heard this before, in the last 20 years? this is the cemetery of retail investors.
0 · Reply
stockboy2030
stockboy2030 Jan. 22 at 12:33 AM
$GOVX 🔥🔥🔥🔥
0 · Reply
L7_Trading
L7_Trading Jan. 21 at 9:14 PM
Looks like they are going to Halt-Up YGHJ in to Close... YHGJ is breaking out now.. Are they pumping up ticker YHGJ for 400% today!? Its insane what's going on in this crazy market.. Looks like all eyes are going to YHGJ now.. $TNXP $GOVX $IXHL $USAR minerals
1 · Reply
DeezNuttz
DeezNuttz Jan. 21 at 2:50 PM
$GOVX
0 · Reply
QuantitativeTrading_
QuantitativeTrading_ Jan. 21 at 1:39 PM
$GOVX Spotlight – 2026 could be the year! Following an upbeat #JPM26 update, GeoVax is pointing to a major inflection point. Key drivers: multiple late-stage clinical trials, regulatory milestones, and manufacturing ramps across their diversified pipeline. Investors are watching closely as 2026 could set the stage for accelerated growth and value creation in biotech. If this helps, tap @QuantitativeTrading_
0 · Reply
FeliciaMath
FeliciaMath Jan. 21 at 1:31 PM
still holding $BCTX, $GOVX, $RIME.
1 · Reply
AZOZ
AZOZ Jan. 21 at 12:36 PM
$GOVX Oversold swing idea 💡
0 · Reply
Ueberschlaefer
Ueberschlaefer Jan. 21 at 2:25 AM
$GOVX hundreds of millions of dollars spent over two decades for nothing. only in america.
0 · Reply
Idonno
Idonno Jan. 20 at 9:09 PM
$GOVX Rather than the slow climb down dragging investors hard earned cash to a shell do nothing company just delist this garbage
0 · Reply
Nelisso
Nelisso Jan. 20 at 4:12 PM
If you’ve ever wanted to catch a short squeeze early instead of watching it rip after the fact, this group is built for that. Sharing momentum, setups, and what we’re watching as it develops, not when it’s already gone. Click link and join for Free ⭐ $AMCR $VMAR $VSME $GOVX +
0 · Reply
stockboy2030
stockboy2030 Jan. 20 at 2:44 PM
$GOVX 🔥🔥🔥🔥🎈🎈🎈🔥🦵🦵🦵
0 · Reply